Combined medico‐surgical strategy for invasive sino‐orbito‐cerebral breakthrough fungal infection with Hormographiella aspergillata in an acute leukaemia patient

Hormographiella aspergillata is a rare causative agent of invasive filamentous breakthrough infection, mostly arising after echinocandin exposure. We report a neutropenic patient who developed a severe sino‐orbito‐cerebral H. aspergillata infection while receiving empirical caspofungin, successfully controlled by an aggressive strategy associating surgical debridement and combined high‐dose regimen of antifungal drugs.

[1]  Hormographiella aspergillata,et al.  Fatal Pulmonary Infection Caused by the Basidiomycete Hormographiella aspergillata , 2017 .

[2]  C. Récher,et al.  Concomitant cases of disseminated Geotrichum clavatum infections in patients with acute myeloid leukemia , 2014, Leukemia & lymphoma.

[3]  J. Meis,et al.  ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[4]  R. Fanin,et al.  Multicentre surveillance study on feasibility, safety and efficacy of antifungal combination therapy for proven or probable invasive fungal diseases in haematological patients: the SEIFEM real‐life combo study , 2013, Mycoses.

[5]  C. Elie,et al.  A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007). , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  D. Kontoyiannis,et al.  Epidemiology and clinical manifestations of mucormycosis. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  A. Thiébaut,et al.  European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update , 2011, Bone Marrow Transplantation.

[8]  M. Weisser,et al.  Hormographiella aspergillata: an emerging mould in acute leukaemia patients? , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[9]  O. Lortholary,et al.  Breakthrough Hormographiella aspergillata Infections Arising in Neutropenic Patients Treated Empirically with Caspofungin , 2010, Journal of Clinical Microbiology.

[10]  D. Penso-Assathiany,et al.  Microsporum praecox: Molecular Identification of a New Case and Review of the Literature , 2010, Mycopathologia.

[11]  R. Ramani,et al.  Rhizomucor variabilis var. regularior and Hormographiella aspergillata Infections in a Leukemic Bone Marrow Transplant Recipient with Refractory Neutropenia , 2009, Journal of Clinical Microbiology.

[12]  C. Lass‐Flörl The changing face of epidemiology of invasive fungal disease in Europe , 2009, Mycoses.

[13]  E. Anaissie,et al.  Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  E. Verbeken,et al.  Fatal pulmonary infection in a leukaemic patient caused by Hormographiella aspergillata. , 2005, Journal of medical microbiology.

[15]  D. Denning,et al.  Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  R. DeMarco,et al.  Invasive Fungal Rhinosinusitis in Immunocompromised Patients , 2004, Rhinology.

[17]  K. Bartz-Schmidt,et al.  Chronic basidiomycetous endophthalmitis after extracapsular cataract extraction and intraocular lens implantation , 1996, Graefe's Archive for Clinical and Experimental Ophthalmology.

[18]  J. Guarro,et al.  Molecular characterization, relatedness and antifungal susceptibility of the basidiomycetous hormographiella species and Coprinus cinereus from clinical and environmental sources , 1996, Antonie van Leeuwenhoek.

[19]  G. S. de Hoog,et al.  A pulmonary infection caused by Coprinus cinereus (Hormographiella aspergillata) diagnosed after a neutropenic episode. , 2002, Medical mycology.

[20]  M. T. Hampton Atlas of Clinical Fungi , 1997 .

[21]  L. Horn,et al.  Rare fatal simultaneous mould infection of the lung caused by Aspergillus flavus and the basidiomycete Coprinus sp. in a leukemic patient. , 1997, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[22]  D. Speller,et al.  Endocarditis caused by a Coprinus species: a fungus of the toadstool group. , 1971, Journal of medical microbiology.